Carlo Giaquinto
University of Padua
388 Papers
2.1K Citations
Carlo Giaquinto is an academic researcher from University of Padua. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 54, co-authored 321 publications. Previous affiliations of Carlo Giaquinto include Boston Children's Hospital & UCL Institute of Child Health.
Chat about Author
Papers
European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe.
Timo Vesikari,Pierre Van Damme,Carlo Giaquinto,James J. Gray,Jacek Mrukowicz,Ron Dagan,Alfredo Guarino,Hania Szajewska,Vytautas Usonis +8 more
TL;DR: This paper presents a systematic literature review and meta-analyses showing clear trends in prognosis for vaccine-preventable disease in children aged five to eight years of age and indicates that vaccination and infection are more closely related than previously thought.
Use of antidepressant medication in pregnancy and adverse neonatal outcomes: A population-based investigation.
TL;DR: Untreated depression and antidepressant use during pregnancy may have negative consequences for births and there are still conflicting data on the potential harmful effects of prenatal antidepressant treatment on child health.
•Journal Article
EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection.
Gianluca Trifirò,Vaishali Patadia,Martijn J. Schuemie,Preciosa M. Coloma,Rosa Gini,Ron M. C. Herings,Julia Hippisley-Cox,Giampiero Mazzaglia,Carlo Giaquinto,Lorenza Scotti,Lars Pedersen,Paul Avillach,Miriam C. J. M. Sturkenboom,Johan van der Lei +13 more
TL;DR: It seems that EU-ADR longitudinal database network may complement traditional spontaneous reporting system for signal detection, especially for those adverse events that are frequent in general population and are not commonly thought to be drug-induced.
COVID-19 in Infants Less than 3 Months: Severe or Not Severe Disease?
Daniele Donà,Carlotta Montagnani,Costanza Di Chiara,Elisabetta Venturini,Luisa Galli,Andrea Lo Vecchio,Marco Denina,Nicole Olivini,Eugenia Bruzzese,Andrea Campana,Roberta Giacchero,Filippo Salvini,Antonella Meloni,Matteo Ponzoni,Sandra Trapani,Elena Rossi,Mary Haywood Lombardi,Raffaele Badolato,Luca Pierri,Giulia Pruccoli,Sara Rossin,Claudia Colomba,Salvatore Cazzato,Ilaria Pacati,Giangiacomo Nicolini,Luca Pierantoni,Sonia Bianchini,Andrzej Krzysztofiak,Silvia Garazzino,Carlo Giaquinto,Guido Castelli Gattinara +30 more
TL;DR: The percentage of infants with severe COVID-19 varies widely according to the score systems, and a unique clinical score should be designed for neonates and infants with CO VID-19.
Antigen detection, virus culture, polymerase chain reaction, and in vitro antibody production in the diagnosis of vertically transmitted HIV-1 infection
A. De Rossi,A. E. Ades,Fabrizio Mammano,A. Del Mistro,Alberto Amadori,Carlo Giaquinto,Luigi Chieco-Bianchi +6 more
TL;DR: All these assays were found to be more sensitive than antigen detection for HIV-1 infection diagnosis, but the antigenaemia was shown to be a useful prognostic marker of disease onset.